ALX-404C

N/A

Report date: 2024/12/24 13:21:03
NME

Base Information

Drug NameALX-404C
Drug Alias NameALX404CALX-40-4CALX-404CALX40-4 +[6] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionHuman Immunodeficiency Virus tat Gene Products inhibitors
TargetsHuman Immunodeficiency Virus tat Gene Products
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesShire Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShire Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A